Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (12)

2024

  1. Epigenetic-based differentiation therapy for Acute Myeloid Leukemia

    Nature Communications, Vol. 15, Núm. 1

  2. PVR (CD155) epigenetic status mediates immunotherapy response in multiple myeloma

    Leukemia

2022

  1. ALAD Inhibition by Porphobilinogen Rationalizes the Accumulation of δ-Aminolevulinate in Acute Porphyrias

    Biochemistry, Vol. 61, Núm. 21, pp. 2409-2416

  2. CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome

    Science Advances, Vol. 8, Núm. 39

  3. Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts

    American Journal of Hematology

2021

  1. Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma

    Leukemia, Vol. 35, Núm. 5, pp. 1438-1450

  2. Gene expression derived from alternative promoters improves prognostic stratification in multiple myeloma

    Leukemia, Vol. 35, Núm. 10, pp. 3012-3016

2017

  1. In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer

    Scientific Reports, Vol. 7, Núm. 1

2014

  1. Heterogeneous micromechanical properties of the extracellular matrix in healthy and infarcted hearts

    Acta Biomaterialia, Vol. 10, Núm. 7, pp. 3235-3242

2012

  1. Integrating tracer-based metabolomics data and metabolic fluxes in a linear fashion via Elementary Carbon Modes

    Metabolic Engineering, Vol. 14, Núm. 4, pp. 344-353

2011

  1. Do elementary flux modes combine linearly at the "atomic" level? Integrating tracer-based metabolomics data and elementary flux modes

    BioSystems, Vol. 105, Núm. 2, pp. 140-146

2010

  1. Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer

    BMC Genomics, Vol. 11, Núm. 1